(SNPS) Synopsys - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8716071076

EDA, Verification, IP, FPGA, TCAD

SNPS EPS (Earnings per Share)

EPS (Earnings per Share) of SNPS over the last years for every Quarter: "2020-10": 1.58, "2021-01": 1.52, "2021-04": 1.7, "2021-07": 1.81, "2021-10": 1.82, "2022-01": 2.4, "2022-04": 2.5, "2022-07": 2.1, "2022-10": 1.91, "2023-01": 2.62, "2023-04": 2.54, "2023-07": 2.88, "2023-10": 3.17, "2024-01": 3.56, "2024-04": 3, "2024-07": 3.43, "2024-10": 3.4, "2025-01": 3.03, "2025-04": 3.67, "2025-07": 3.39, "2025-10": 0,

SNPS Revenue

Revenue of SNPS over the last years for every Quarter: 2020-10: 1025.557, 2021-01: 970.208, 2021-04: 1023.402, 2021-07: 1055.567, 2021-10: 1150.835, 2022-01: 1270.826, 2022-04: 1279, 2022-07: 1244.115, 2022-10: 1276.626, 2023-01: 1365.307, 2023-04: 1268.281, 2023-07: 1355.742, 2023-10: 1466.469, 2024-01: 1514.31, 2024-04: 1455.731, 2024-07: 1523.06, 2024-10: 1631.304, 2025-01: 1456.317, 2025-04: 1602.984, 2025-07: 1739.737, 2025-10: null,

Description: SNPS Synopsys September 25, 2025

Synopsys Inc. (NASDAQ: SNPS) delivers electronic design automation (EDA) software that enables the design and verification of integrated circuits (ICs) across a full stack of digital, custom, and system-level solutions. Its product portfolio is split into two operating segments: Design Automation – covering digital implementation, verification (including static, formal, simulation, emulation, and FPGA-based prototyping), TCAD, mask synthesis, and AI-enhanced tools – and Design IP – supplying reusable silicon intellectual property such as UCIe, USB, PCI Express, DDR, Ethernet, MIPI, HDMI, processor cores, security blocks, automotive-grade IP, and SoC infrastructure components.

Key financial metrics from the most recent fiscal year (FY 2024) show total revenue of $5.8 billion, a 9 % year-over-year increase driven largely by higher demand for AI-focused EDA tools and expanding IP licensing, with GAAP earnings per share of $5.30 and a gross margin of 78 %. R&D expenditures remain high at roughly 30 % of revenue, reflecting the capital-intensive nature of maintaining technology leadership in a market where the top three EDA vendors collectively hold about 70 % of total spend.

Macro-level drivers that shape Synopsys’ outlook include the ongoing semiconductor fab capacity expansion, the acceleration of AI-accelerator chip designs, and the shift toward heterogeneous integration (e.g., chiplet-based architectures) that raises the relevance of standardized IP such as UCIe and high-speed interconnects. Conversely, a slowdown in consumer electronics cycles or a prolonged downturn in fab utilization could compress IP licensing revenues.

Investors seeking a data-driven assessment of Synopsys’ valuation and risk profile may find it useful to explore the detailed analyst models available on ValueRay for a deeper quantitative comparison.

SNPS Stock Overview

Market Cap in USD 83,149m
Sub-Industry Application Software
IPO / Inception 1992-02-26

SNPS Stock Ratings

Growth Rating 43.2%
Fundamental 61.1%
Dividend Rating -
Return 12m vs S&P 500 -28.6%
Analyst Rating 4.55 of 5

SNPS Dividends

Currently no dividends paid

SNPS Growth Ratios

Growth Correlation 3m -77.4%
Growth Correlation 12m -6.9%
Growth Correlation 5y 87%
CAGR 5y 18.13%
CAGR/Max DD 3y (Calmar Ratio) 0.45
CAGR/Mean DD 3y (Pain Ratio) 1.71
Sharpe Ratio 12m 0.03
Alpha -34.31
Beta 1.097
Volatility 35.36%
Current Volume 1699.4k
Average Volume 20d 1789.6k
Stop Loss 433.5 (-4.5%)
Signal 0.26

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (2.00b TTM) > 0 and > 6% of Revenue (6% = 385.8m TTM)
FCFTA 0.03 (>2.0%) and ΔFCFTA -5.87pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 33.46% (prev 43.51%; Δ -10.05pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.03 (>3.0%) and CFO 1.44b <= Net Income 2.00b (YES >=105%, WARN >=100%)
Net Debt (12.61b) to EBITDA (1.84b) ratio: 6.84 <= 3.0 (WARN <= 3.5)
Current Ratio 1.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (161.7m) change vs 12m ago 3.56% (target <= -2.0% for YES)
Gross Margin 77.74% (prev 77.35%; Δ 0.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 21.48% (prev 51.16%; Δ -29.68pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 5.50 (EBITDA TTM 1.84b / Interest Expense TTM 266.4m) >= 6 (WARN >= 3)

Altman Z'' 1.78

(A) 0.04 = (Total Current Assets 5.60b - Total Current Liabilities 3.44b) / Total Assets 48.23b
(B) 0.20 = Retained Earnings (Balance) 9.87b / Total Assets 48.23b
(C) 0.05 = EBIT TTM 1.47b / Avg Total Assets 29.94b
(D) 0.47 = Book Value of Equity 9.64b / Total Liabilities 20.62b
Total Rating: 1.78 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 61.08

1. Piotroski 3.50pt = -1.50
2. FCF Yield 1.36% = 0.68
3. FCF Margin 20.25% = 5.06
4. Debt/Equity 0.55 = 2.35
5. Debt/Ebitda 6.84 = -2.50
6. ROIC - WACC (= 0.65)% = 0.81
7. RoE 14.31% = 1.19
8. Rev. Trend 88.97% = 6.67
9. EPS Trend -33.90% = -1.69

What is the price of SNPS shares?

As of November 03, 2025, the stock is trading at USD 453.82 with a total of 1,699,437 shares traded.
Over the past week, the price has changed by -2.49%, over one month by -3.68%, over three months by -28.65% and over the past year by -13.48%.

Is Synopsys a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Synopsys is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 61.08 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SNPS is around 417.30 USD . This means that SNPS is currently overvalued and has a potential downside of -8.05%.

Is SNPS a buy, sell or hold?

Synopsys has received a consensus analysts rating of 4.55. Therefore, it is recommended to buy SNPS.
  • Strong Buy: 15
  • Buy: 4
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the SNPS price?

Issuer Target Up/Down from current
Wallstreet Target Price 556.4 22.6%
Analysts Target Price 556.4 22.6%
ValueRay Target Price 466.1 2.7%

SNPS Fundamental Data Overview October 20, 2025

Market Cap USD = 83.15b (83.15b USD * 1.0 USD.USD)
P/E Trailing = 60.5738
P/E Forward = 31.8471
P/S = 12.9207
P/B = 3.1691
P/EG = 6.1778
Beta = 1.097
Revenue TTM = 6.43b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 1.84b USD
Long Term Debt = 14.32b USD (from longTermDebt, last quarter)
Short Term Debt = 149.6m USD (from shortTermDebt, last quarter)
Debt = 15.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.61b USD (from netDebt column, last quarter)
Enterprise Value = 95.70b USD (83.15b + Debt 15.14b - CCE 2.59b)
Interest Coverage Ratio = 5.50 (Ebit TTM 1.47b / Interest Expense TTM 266.4m)
FCF Yield = 1.36% (FCF TTM 1.30b / Enterprise Value 95.70b)
FCF Margin = 20.25% (FCF TTM 1.30b / Revenue TTM 6.43b)
Net Margin = 31.07% (Net Income TTM 2.00b / Revenue TTM 6.43b)
Gross Margin = 77.74% ((Revenue TTM 6.43b - Cost of Revenue TTM 1.43b) / Revenue TTM)
Gross Margin QoQ = 78.13% (prev 80.14%)
Tobins Q-Ratio = 1.98 (Enterprise Value 95.70b / Total Assets 48.23b)
Interest Expense / Debt = 0.97% (Interest Expense 146.5m / Debt 15.14b)
Taxrate = -27.98% (negative due to tax credits) (-53.0m / 189.3m)
NOPAT = 1.88b (EBIT 1.47b * (1 - -27.98%)) [negative tax rate / tax credits]
Current Ratio = 1.62 (Total Current Assets 5.60b / Total Current Liabilities 3.44b)
Debt / Equity = 0.55 (Debt 15.14b / totalStockholderEquity, last quarter 27.61b)
Debt / EBITDA = 6.84 (Net Debt 12.61b / EBITDA 1.84b)
Debt / FCF = 9.69 (Net Debt 12.61b / FCF TTM 1.30b)
Total Stockholder Equity = 13.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.14% (Net Income 2.00b / Total Assets 48.23b)
RoE = 14.31% (Net Income TTM 2.00b / Total Stockholder Equity 13.96b)
RoCE = 5.18% (EBIT 1.47b / Capital Employed (Equity 13.96b + L.T.Debt 14.32b))
RoIC = 9.35% (NOPAT 1.88b / Invested Capital 20.06b)
WACC = 8.70% (E(83.15b)/V(98.29b) * Re(10.06%) + D(15.14b)/V(98.29b) * Rd(0.97%) * (1-Tc(-0.28)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.18%
[DCF Debug] Terminal Value 70.84% ; FCFE base≈1.18b ; Y1≈1.15b ; Y5≈1.17b
Fair Price DCF = 80.34 (DCF Value 14.92b / Shares Outstanding 185.7m; 5y FCF grow -3.26% → 3.0% )
EPS Correlation: -33.90 | EPS CAGR: -55.82% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.97 | Revenue CAGR: 11.91% | SUE: -0.16 | # QB: 0

Additional Sources for SNPS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle